ArticleJournal of neurosurgery. Case lessons2025
Hypercalcemia associated with relapsed medulloblastoma due to bone metastasis: illustrative case.
Article in Journal of neurosurgery. Case lessons, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Fulminant extraneural metastases in MYC-amplified Group 3 medulloblastoma: a pediatric case report.Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundMedulloblastoma can cause extraneural metastasis, particularly to the bones. However, only a few reports have shown that hypercalcemia occurs with medulloblastoma, and there are no reports on hypercalcemia causing consciousness disturbance. OBSERVATIONS: A 17-year-old male patient was treated for medulloblastoma with spinal and intracranial metastasis. He underwent subtotal resection, followed by radiotherapy to the craniospinal axis, posterior fossa, and primary site, as well as high-dose chemotherapy with autologous hematopoietic stem cell transplantation. He achieved complete remission after the initial treatment. However, 30 months after tumor resection, he developed headache, nausea, fatigue, and pain in the limbs and back, followed by consciousness disturbance. He had severe hypercalcemia (17.7 mg/dL) and multiple bone metastases. His symptoms improved with hypercalcemia treatment, and salvage chemotherapy resulted in complete remission of the recurrent disease. LESSONS: Previous studies have not reported consciousness disturbance caused by hypercalcemia due to medulloblastoma bone metastasis. Hypercalcemia causes various symptoms, affecting the neurological, cardiac, and gastrointestinal systems. Some of its symptoms, such as fatigue, nausea, vomiting, and bradycardia, are similar to those of increased intracranial pressure. Therefore, hypercalcemia attributed to bone metastases should be considered in the differential diagnosis of consciousness disturbance during the course of medulloblastoma. https://thejns.org/doi/10.3171/CASE25318.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.